Welcome to LookChem.com Sign In|Join Free
  • or
6-(3-Fluorophenyl)-nicotinic acid is a chemical compound with the molecular formula C13H9NO2F. It is a derivative of nicotinic acid, also known as vitamin B3, and features a 3-fluorophenyl group attached to the nicotinic acid core. 6-(3-Fluorophenyl)-nicotinic acid possesses unique structural and functional properties, making it a promising candidate for medicinal chemistry and drug discovery.

582325-22-2

Post Buying Request

582325-22-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

582325-22-2 Usage

Uses

Used in Medicinal Chemistry:
6-(3-Fluorophenyl)-nicotinic acid is used as a chemical intermediate for the synthesis of various pharmaceuticals and biologically active compounds. Its unique structure allows it to interact with specific biological targets, potentially modulating their functions and leading to the development of new therapeutic agents.
Used in Drug Discovery:
In the pharmaceutical industry, 6-(3-Fluorophenyl)-nicotinic acid is utilized as a lead compound in drug discovery efforts. Its ability to bind and influence biological targets makes it a valuable tool for identifying novel therapeutic agents with potential applications in treating various diseases and conditions.
Used in Research and Development:
6-(3-Fluorophenyl)-nicotinic acid is employed as a research compound in academic and industrial laboratories. Its unique properties and potential interactions with biological systems make it an interesting subject for further investigation, contributing to the advancement of knowledge in medicinal chemistry and related fields.

Check Digit Verification of cas no

The CAS Registry Mumber 582325-22-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 5,8,2,3,2 and 5 respectively; the second part has 2 digits, 2 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 582325-22:
(8*5)+(7*8)+(6*2)+(5*3)+(4*2)+(3*5)+(2*2)+(1*2)=152
152 % 10 = 2
So 582325-22-2 is a valid CAS Registry Number.

582325-22-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 6-(3-fluorophenyl)pyridine-3-carboxylic acid

1.2 Other means of identification

Product number -
Other names 6-(3-fluorophenyl)-3-pyridinecarboxylic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:582325-22-2 SDS

582325-22-2Relevant academic research and scientific papers

NICOTINAMIDE DERIVATIVES

-

Page/Page column 202, (2010/01/12)

The present invention relates to compounds of the formula (I) and pharmaceutically acceptable salts and solvates thereof, wherein the substituents are defined herein, to compositions containing such compounds and to the uses of such compounds for the trea

Design and synthesis of 6-phenylnicotinamide derivatives as antagonists of TRPV1

Westaway, Susan M.,Thompson, Mervyn,Rami, Harshad K.,Stemp, Geoffrey,Trouw, Leontine S.,Mitchell, Darren J.,Seal, Jon T.,Medhurst, Stephen J.,Lappin, Sarah C.,Biggs, James,Wright, James,Arpino, Sandra,Jerman, Jeffrey C.,Cryan, Jennifer E.,Holland, Vicky,Winborn, Kim Y.,Coleman, Tanya,Stevens, Alexander J.,Davis, John B.,Gunthorpe, Martin J.

scheme or table, p. 5609 - 5613 (2009/06/18)

6-Phenylnicotinamide (2) was previously identified as a potent TRPV1 antagonist with activity in an in vivo model of inflammatory pain. Optimization of this lead through modification of both the biaryl and heteroaryl components has resulted in the discovery of 6-(4-fluorophenyl)-2-methyl-N-(2-methylbenzothiazol-5-yl)nicotinamide (32; SB-782443) which possesses an excellent overall profile and has been progressed into pre-clinical development.

Nicotinamide Derivatives

-

Page/Page column 20; 30, (2008/12/06)

The present invention relates to compounds of formula (I) and pharmaceutically acceptable salts and solvates thereof, wherein the substituents are as defined herein, compositions containing such compounds and the uses of such compounds for the treatment o

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 582325-22-2